Cited by 187Cell death mechanisms and regulationinterferon and immune responsesCancer Immunotherapy and Biomarkers

ZBP1-MLKL necroptotic signaling potentiates radiation-induced antitumor immunity via intratumoral STING pathway activation

Open access
Yang, Yuanqin, Wu, Meng, Cao, Dongqing, Yang, Chao, Jin, Jingsi, Wu, Lingling, Hong, Xiaochuan, Li, Wenwen +10 more·2021·Science Advances

Abstract

ZBP1-MLKL necroptotic signaling bridges tumor cell damage to antitumor immune responses after radiation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1126/sciadv.abf6290

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • It has been proposed that tumor cell-intrinsic STING enhances tumor immunogenicity by increasing immune cell activation and triggering tumor cell regression.

    “it has been proposed that tumor cell-intrinsic STING enhances tumor immunogenicity by increasing immune cell activation and triggering tumor cell regression.47–49”

    From Functional tumor cell-intrinsic STING, not host STING, drives local and systemic antitumor immunity and therapy efficacy following cryoablation (2023) · cites this paper as [49]

    The Results section reports that tumors lacking STING had poorer control after radiation and fewer activated, tumor-specific CD8+ T cells, supporting a role for tumor cell–intrinsic STING in antitumor immunity. The evidence is specific to radiation-treated tumors; it reports tumor control rather than explicitly showing that STING triggers tumor regression more generally. No page number is available in our copy. (LLM, conf=0.83)

    Experimental — accuracy not yet measured
  • Previous studies have suggested that the tumor cell-intrinsic STING pathway may be essential in triggering antitumor immunity in other contexts.

    “Previous studies have suggested that the tumor cell-intrinsic STING pathway may be essential in triggering antitumor immunity in other contexts.47–49”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Yang, Y., Wu, M., Cao, D., Yang, C., Jin, J., Wu, L., Hong, X., Li, W., Lu, L., Li, J., Wang, X., Meng, X., Zhang, Z., Cheng, J., Ye, Y., Xiao, H., Yu, J., & Deng, L.
Affiliations
  • Shanghai Jiao Tong University (CN)
  • Shandong Tumor Hospital (CN)
  • Fudan University (CN)
  • Chinese Academy of Sciences (CN)
Corresponding author
  • Yu, Jinming
  • Deng, Liufu
Venue
Science Advances
Published
2021-10-08
Volume
7
Issue
41
Pages
eabf6290-eabf6290
ISSN
2375-2548 (ISSN-L)
OpenAlex
W3204117137
Cited by
187
References
45
Citations by year
2026: 37 · 2025: 37 · 2024: 42 · 2023: 48 · 2022: 23
FWCI
8.87
Type
journal article
Language
en
Open access
Locations
  • Science Advances (publishedVersion)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
  • Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Keywords
necroptosis, ZBP1, MLKL, STING pathway, cGAS-STING pathway, type I interferon, cytoplasmic DNA, caspase-8, radiotherapy, tumor cell-intrinsic signaling, radioimmunotherapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review